Translation, Cultural Adaptation, Validation, and Reliability of Persian-Revised Heart Failure Compliance Questionnaire
Background: Compliance with health-related behaviors is a dilemma among heart failure (HF) patients. The present study aimed to assess the validity and reliability of a Persian translation of the revised heart failure compliance questionnaire (RHFCQ) in Iranian HF sufferers.
Methods: This methodological study was performed on outpatient HF individuals referred to a heart clinic in Isfahan, Iran. The forward-backward translation method was used for translation. Twenty subjects were invited to express their opinions on the provided items concerning simplicity and understandability. Twelve experts were invited to rate the items regarding the content validity index (CVI). Cronbach’s α was used to evaluate internal consistency. The patients were asked to complete the questionnaire for the second time after 2 weeks to investigate test-retest reliability using the intraclass correlation coefficient (ICC).
Results: There were no obvious difficulties during the translation and assessment of the simplicity and comprehensiveness of the questionnaire items. The CVI of the items ranged from 0.833 to 1.000. Totally, 150 patients (age: 64.60±15.00 y, males: 58.0%) filled in the questionnaire twice with no missing data. The highest and lowest compliance rates were attributed to alcohol and exercise domains, respectively (83.00±7.70% and 45.55±12.00%, respectively). Cronbach’s α was 0.629. After the omission of 3 items related to smoking and alcohol cessation, Cronbach’s α rose to 0.655. The ICC showed an acceptable value of 0.576 (95% CI, 0.462 to 0.673).
Conclusion: The modified Persian RHFCQ is a simple and meaningful tool with acceptable moderate reliability and good validity for assessing compliance in Iranian HF patients.
2. McMurray JJV, Stewart S. The Burden of Heart Failure. Eur Heart J Suppl 2002;4(suppl_D):D50-D58.
3. Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, Jaarsma T, Krum H, Rastogi V, Rohde LE. Heart Failure: Preventing Disease and Death Worldwide. ESC Heart Fail 2014;1:4-25.
4. Sahle BW, Owen AJ, Mutowo MP, Krum H, Reid CM. Prevalence of Heart Failure in Australia: A Systematic Review. BMC Cardiovasc Disord 2016;16:32.
5. Hobbs FR, Roalfe AK, Davis RC, Davies MK, Hare R. Prognosis of All-Cause Heart Failure and Borderline Left Ventricular Systolic Dysfunction: 5 Year Mortality Follow-up of the Echocardiographic Heart of England Screening Study (Echoes). Eur Heart J 2007;28:1128-1134.
6. Shafie AA, Tan YP, Ng CH. Systematic review of economic burden of heart failure. Heart Fail Rev 2018;23:131-145.
7. Heidarpour M, Bashiri S, Vakhshoori M, Heshmat-Ghahdarijani K, Khanizadeh F, Ferdowsian S, Shafie D. The association between platelet-to-lymphocyte ratio with mortality among patients suffering from acute decompensated heart failure. BMC Cardiovasc Disord 2021;21:454.
8. Amirpour A, Vakhshoori M, Zavar R, Zarei H, Sadeghi M, Yavari B. The Effect of 3-Month Growth Hormone Administration and 12-Month Follow-Up Duration among Heart Failure Patients Four Weeks after Myocardial Infarction: A Randomized Double-Blinded Clinical Trial. Cardiovasc Ther 2021;2021:2680107.
9. Yadollahi Farsani A, Vakhshoori M, Mansouri A, Heidarpour M, Nikouei F, Garakyaraghi M, Sarrafzadegan N, Shafie D. Relation between Hemoconcentration Status and Readmission Plus Mortality Rate Among Iranian Individuals with Decompensated Heart Failure. Int J Prev Med 2020;11:163.
10. Rahimi F, Vakhshoori M, Heidarpour M, Nouri F, Heshmat-Ghahdarijani K, Fakhrolmobasheri M, Shafie D. Metolazone Add-On Therapy in Heart Failure: A Cohort Study from Persian Registry of Cardiovascular Disease/Heart Failure (PROVE/HF). Crit Care Res Pract 2021;2021:3820292.
11. Bondariyan N, Vakhshoori M, Sadeghpour N, Shafie D. Prognostic Value of Shock Index, Modified Shock Index, and Age-Adjusted Derivatives in Prediction of In-Hospital Mortality in Patients with Acute Decompensated Heart Failure: Persian Registry of Cardiovascular Disease/ Heart Failure Study. Anatol J Cardiol 2022;26:210-217.
12. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola V-P, Jankowska EA. 2016 Esc Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (Esc) Developed with the Special Contribution of the Heart Failure Association (Hfa) of the Esc. Eur Heart J 2016;37:2129-2200.
13. Jankowska-Polańska B, Świątoniowska-Lonc N, Sławuta A, Krówczyńska D, Dudek K, Mazur G. Patient-Reported Compliance in Older Age Patients with Chronic Heart Failure. Plos one 2020;15:e0231076.
14. van der Wal MH, Jaarsma T. Adherence in Heart Failure in the Elderly: Problem and Possible Solutions. Int J Cardiol 2008;125:203-208.
15. Dontje ML, van der Wal MH, Stolk RP, Brügemann J, Jaarsma T, Wijtvliet PE, van der Schans CP, de Greef MH. Daily Physical Activity in Stable Heart Failure Patients. J Cardiovasc Nurs 2014;29:218-226.
16. Evangelista L, Doering LV, Dracup K, Westlake C, Hamilton M, Fonarow GC. Compliance behaviors of elderly patients with advanced heart failure. J Cardiovasc Nurs 2003;18:197-206; quiz 207-208.
17. Evangelista LS, Berg J, Dracup K. Relationship between psychosocial variables and compliance in patients with heart failure. Heart Lung 2001;30:294-301.
18. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 2000;25:3186-3191.
19. Tsang S, Royse CF, Terkawi AS. Guidelines for developing, translating, and validating a questionnaire in perioperative and pain medicine. Saudi J Anaesth 2017;11(Suppl 1):S80-S89.
20. Zamanzadeh V, Ghahramanian A, Rassouli M, Abbaszadeh A, Alavi-Majd H, Nikanfar AR. Design and Implementation Content Validity Study: Development of an instrument for measuring Patient-Centered Communication. J Caring Sci 2015;4:165-178.
21. Eghbali-Babadi M, Feizi A, Khosravi A, Nouri F, Taheri M, Sarrafzadegan N. Development and evaluation of the psychometric properties of a hypertension self-care questionnaire. ARYA Atheroscler 2019;15:241-249.
22. Keszei AP, Novak M, Streiner DL. Introduction to Health Measurement Scales. J Psychosom Res 2010;68:319-323.
23. Koh YLE, Lua YHA, Hong L, Bong HSS, Yeo LSJ, Tsang LPM, Ong KZ, Wong SWS, Tan NC. Using a Web-Based Approach to Assess Test-Retest Reliability of the "Hypertension Self-Care Profile" Tool in an Asian Population: A Validation Study. Medicine (Baltimore) 2016;95:e2955.
24. Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, Bouter LM, de Vet HC. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007;60:34-42.
25. Gomes JL, Águeda AF, Heaney A, Duarte C, Lopes C, Costa T, Marona J, Rodrigues-Manica S, Maia S, Costa M, Branco JC, McKenna SP, Barcelos A, Pimentel-Santos FM. Translation, cross-cultural adaptation and validation of the Osteoarthritis Quality of Life (OAQoL) questionnaire for use in Portugal. Rheumatol Int 2019;39:715-722.
26. Maneesriwongul W, Dixon JK. Instrument Translation Process: A Methods Review. J Adv Nurs 2004;48:175-186.
27. Jankowska-Polańska B, Kuśnierz M, Dudek K, Jaroch J, Uchmanowicz I. Impact of Cognitive Function on Compliance with Treatment in Heart Failure. J Educ Health Sport 2017;7:392-414.
28. Black G, PhD BAD, Kim Heathcotte RN B, Nikki Mitchell RN B, Sanderson C. The Relationship between Spirituality and Compliance in Patients with Heart Failure. Prog Cardiovasc Nurs 2006;21:128-133.
|Issue||Vol 17 No 4 (2022): J Teh Univ Heart Ctr|
|Heart failure Quality of life; Validation study Surveys and questionnaires Psychometrics Reproducibility of results Iran|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|